KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Non-Current Assets: 2009-2024

Historic Non-Current Assets for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $6.1 billion.

  • Charles River Laboratories International's Non-Current Assets fell 8.10% to $6.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year decrease of 8.10%. This contributed to the annual value of $6.1 billion for FY2024, which is 7.00% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Non-Current Assets of $6.1 billion as of FY2024, which was down 7.00% from $6.6 billion recorded in FY2023.
  • Charles River Laboratories International's Non-Current Assets' 5-year high stood at $6.6 billion during FY2023, with a 5-year trough of $4.3 billion in FY2020.
  • For the 3-year period, Charles River Laboratories International's Non-Current Assets averaged around $6.3 billion, with its median value being $6.2 billion (2022).
  • In the last 5 years, Charles River Laboratories International's Non-Current Assets soared by 34.05% in 2021 and then declined by 7.00% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Assets (Yearly) stood at $4.3 billion in 2020, then surged by 34.05% to $5.8 billion in 2021, then grew by 7.19% to $6.2 billion in 2022, then grew by 6.86% to $6.6 billion in 2023, then decreased by 7.00% to $6.1 billion in 2024.